DPMH oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatric population and to improve pregnancy and lactation-related information in product labeling.
Similar Posts
Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment Public Meeting – 09/24/2025
The Food and Drug Administration (FDA) is holding a hybrid public meeting titled “Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment on 9/24/2025.Fareva Amboise – 09/16/2025
Fareva Amboise – 09/16/2025. Country: France. Record Type: 483C3TI Compass (Knowledge Repository)
Centralized knowledge repository for clinical trial innovationXXX Zone 40K contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use XXX Zone 40K, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Early Alert: Convenience Kit Needle Issue from Integra LifeSciences
Integra LifeSciences is removing certain lots of Microsensor and Cerelink ICP Kits with potential corrosion stains on the included Tuohy Needle.Bayesian Statistical Analysis (BSA) Demonstration Project
C3TI aims to increase experience in Bayesian statistical methods in simple trial settings across sponsors, CDER clinical reviewers, and CDER statisticians, including deepening an understanding of their applicability, opportunities, and challenges.